HCW Biologics (HCWB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.24, +0.81% vs the prior close of $1.23.
- Volume 77.64K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HCWB rises 0.8% to $1.24. Closed at $1.24, +0.81% vs the prior close of $1.23. Day range $1.22–$1.27, opened at $1.23.
HCWB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HCWB rises 0.8% to $1.24
- Closed at $1.24, +0.81% vs the prior close of $1.23. Day range $1.22–$1.27, opened at $1.23.
- Volume was 77.64K shares, 0.2x its 50-day average of 500.84K — lighter than usual.
- Price is -44.7% vs its 50-day average ($2.24) and -71.9% vs its 200-day average ($4.41).
- 52-week range $1.14–$26.13; today's close sits at 0% of that range, 95.3% below the 52-week high.
Oct 15, 2026 — HCWB jumps 5.1% to $1.23
- Closed at $1.23, +5.13% vs the prior close of $1.17. Day range $1.15–$1.28, opened at $1.17.
- Volume was 48.50K shares, 0.1x its 50-day average of 500.83K — lighter than usual.
- Price is -46.2% vs its 50-day average ($2.29) and -72.3% vs its 200-day average ($4.44).
- 52-week range $1.14–$26.85; today's close sits at 0% of that range, 95.4% below the 52-week high.
Oct 14, 2026 — HCWB slides 7.1% to $1.17, a 52-week low, 3 down days in a row
- Closed at $1.17, -7.14% vs the prior close of $1.26. Day range $1.14–$1.26, opened at $1.24.
- Volume was 57.50K shares, 0.1x its 50-day average of 501.03K — lighter than usual.
- Price is -49.8% vs its 50-day average ($2.33) and -73.8% vs its 200-day average ($4.47).
- 52-week range $1.14–$27.30; today's close sits at 0% of that range, 95.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HCWB slides 14.9% to $1.26, a 52-week low on 4.6x normal volume
- Closed at $1.26, -14.86% vs the prior close of $1.48. Day range $1.25–$1.45, opened at $1.30.
- Volume was 2.13M shares, 4.6x its 50-day average of 464.19K — unusually heavy trading.
- Price is -47.1% vs its 50-day average ($2.38) and -72.0% vs its 200-day average ($4.50).
- 52-week range $1.25–$27.30; today's close sits at 0% of that range, 95.4% below the 52-week high.
Oct 12, 2026 — HCWB slides 7.5% to $1.48, a 52-week low
- Closed at $1.48, -7.50% vs the prior close of $1.60. Day range $1.47–$1.60, opened at $1.56.
- Volume was 43.00K shares, 0.1x its 50-day average of 464.62K — lighter than usual.
- Price is -38.9% vs its 50-day average ($2.42) and -67.4% vs its 200-day average ($4.54).
- 52-week range $1.47–$27.57; today's close sits at 0% of that range, 94.6% below the 52-week high.
Oct 9, 2026 — HCWB jumps 4.6% to $1.60
- Closed at $1.60, +4.58% vs the prior close of $1.53. Day range $1.52–$1.73, opened at $1.60.
- Volume was 79.90K shares, 0.2x its 50-day average of 464.91K — lighter than usual.
- Price is -34.9% vs its 50-day average ($2.46) and -65.1% vs its 200-day average ($4.58).
- 52-week range $1.50–$28.14; today's close sits at 0% of that range, 94.3% below the 52-week high.
Oct 8, 2026 — HCWB dips 1.9% to $1.53, a 52-week low, 10 down days in a row
- Closed at $1.53, -1.92% vs the prior close of $1.56. Day range $1.51–$1.61, opened at $1.59.
- Volume was 46.40K shares, 0.1x its 50-day average of 465.07K — lighter than usual.
- Price is -38.5% vs its 50-day average ($2.49) and -66.9% vs its 200-day average ($4.62).
- 52-week range $1.50–$29.28; today's close sits at 0% of that range, 94.8% below the 52-week high.
- That makes 10 straight losses.
Oct 7, 2026 — HCWB dips 0.6% to $1.56, a 52-week low, 9 down days in a row
- Closed at $1.56, -0.64% vs the prior close of $1.57. Day range $1.54–$1.62, opened at $1.55.
- Volume was 30.60K shares, 0.1x its 50-day average of 465.27K — lighter than usual.
- Price is -37.8% vs its 50-day average ($2.51) and -66.5% vs its 200-day average ($4.66).
- 52-week range $1.50–$29.28; today's close sits at 0% of that range, 94.7% below the 52-week high.
- That makes 9 straight losses.
Oct 6, 2026 — HCWB slides 4.3% to $1.57, a 52-week low, 8 down days in a row
- Closed at $1.57, -4.27% vs the prior close of $1.64. Day range $1.55–$1.63, opened at $1.61.
- Volume was 37.70K shares, 0.1x its 50-day average of 465.96K — lighter than usual.
- Price is -37.9% vs its 50-day average ($2.53) and -66.6% vs its 200-day average ($4.70).
- 52-week range $1.50–$29.28; today's close sits at 0% of that range, 94.6% below the 52-week high.
- That makes 8 straight losses.
Oct 5, 2026 — HCWB dips 2.4% to $1.64, a 3-month low, 7 down days in a row
- Closed at $1.64, -2.38% vs the prior close of $1.68. Day range $1.55–$1.69, opened at $1.64.
- Volume was 82.00K shares, 0.2x its 50-day average of 465.46K — lighter than usual.
- Price is -35.7% vs its 50-day average ($2.55) and -65.4% vs its 200-day average ($4.74).
- 52-week range $1.50–$29.28; today's close sits at 1% of that range, 94.4% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — HCWB dips 0.6% to $1.68, 6 down days in a row
- Closed at $1.68, -0.59% vs the prior close of $1.69. Day range $1.65–$1.72, opened at $1.66.
- Volume was 64.60K shares, 0.1x its 50-day average of 466.00K — lighter than usual.
- Price is -34.6% vs its 50-day average ($2.57) and -64.9% vs its 200-day average ($4.79).
- 52-week range $1.50–$29.28; today's close sits at 1% of that range, 94.3% below the 52-week high.
- That makes 6 straight losses.
- SEC filings that day: S-1.
HCWB latest news & SEC filings
Every SEC filing by or about HCWB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 1, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 9, 2026 · Form PRER14A — PRER14A filing
PRER14A filing
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 8, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 31, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 28, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 20, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $121.73K
- Net income: -$5.22M (prior year -$1.93M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$11.58 (prior year -$40.72) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q/A — Quarterly report (amended)
Amended quarterly report
Quarter ended Mar 31, 2026:
- Revenue: $6.50M
- Net income: $3.47M (prior year -$2.20M) (swung to profit vs Mar 31, 2025)
- Diluted EPS: $1.39 (prior year -$11.80) (swung to profit vs Mar 31, 2025)
Things to know before you trade HCWB
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 31, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.07% (largest 19.9%). That is a volatile stock.
- Liquidity: about 869.55K shares (≈$1.08M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.24 vs a range of $1.14–$26.13 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:6 on Jun 30, 2026, 1:40 on Apr 11, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 24 open-market buys, 0 sales; latest: Scott T Garrett bought 7,736 shares on Jul 29, 2026.
- Latest filings: 8-K Sep 24, 2026; 8-K Sep 10, 2026; 8-K Sep 8, 2026.
- Share count: 1.84M shares outstanding (Aug 12, 2026), -14.7% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HCWB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.23 | 1.27 | 1.22 | 1.24 | 77.64K |
| Oct 15, 2026 | 1.17 | 1.28 | 1.15 | 1.23 | 48.50K |
| Oct 14, 2026 | 1.24 | 1.26 | 1.14 | 1.17 | 57.50K |
| Oct 13, 2026 | 1.30 | 1.45 | 1.25 | 1.26 | 2.13M |
| Oct 12, 2026 | 1.56 | 1.60 | 1.47 | 1.48 | 43.00K |
| Oct 9, 2026 | 1.60 | 1.73 | 1.52 | 1.60 | 79.90K |
| Oct 8, 2026 | 1.59 | 1.61 | 1.51 | 1.53 | 46.40K |
| Oct 7, 2026 | 1.55 | 1.62 | 1.54 | 1.56 | 30.60K |
| Oct 6, 2026 | 1.61 | 1.63 | 1.55 | 1.57 | 37.70K |
| Oct 5, 2026 | 1.64 | 1.69 | 1.55 | 1.64 | 82.00K |
| Oct 2, 2026 | 1.66 | 1.72 | 1.65 | 1.68 | 64.60K |
| Oct 1, 2026 | 1.75 | 1.75 | 1.67 | 1.69 | 55.10K |
| Sep 30, 2026 | 1.77 | 1.82 | 1.71 | 1.71 | 48.20K |
| Sep 29, 2026 | 1.81 | 1.85 | 1.75 | 1.75 | 51.40K |
| Sep 28, 2026 | 1.86 | 1.89 | 1.71 | 1.82 | 102.20K |
| Sep 25, 2026 | 1.88 | 2.00 | 1.81 | 1.93 | 416.90K |
| Sep 24, 2026 | 1.69 | 3.12 | 1.67 | 1.99 | 13.67M |
| Sep 23, 2026 | 1.81 | 1.83 | 1.61 | 1.66 | 161.20K |
| Sep 22, 2026 | 1.91 | 1.98 | 1.70 | 1.81 | 132.90K |
| Sep 21, 2026 | 1.95 | 2.02 | 1.87 | 1.91 | 59.10K |
About HCW Biologics
HCW Biologics (HCWB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIRAMAR, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1828673.
HCWB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Scott T Garrett | Director | Jul 31, 2026 |
| Hing C Wong | Chief Executive Officer | Jul 31, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Rebecca Byam | Chief Financial Officer | May 27, 2026 |
| Lee Flowers | SVP of Business Development | Jul 31, 2026 |
| Hing C Wong | Chief Executive Officer | Jul 31, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Scott T Garrett | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Scott T Garrett | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Scott T Garrett | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Scott T Garrett | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Hing C Wong | Buy | 23,210 | $2.59 |
| Jul 29, 2026 | Hing C Wong | Buy | 23,210 | $2.59 |
| Jul 29, 2026 | Hing C Wong | Buy | 23,210 | $2.59 |
| Jul 29, 2026 | Hing C Wong | Buy | 23,210 | $2.59 |
| Jul 29, 2026 | Lee Flowers | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Lee Flowers | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Lee Flowers | Buy | 7,736 | $2.59 |
| Jul 29, 2026 | Lee Flowers | Buy | 7,736 | $2.59 |
| May 22, 2026 | Rebecca Byam | Buy | 14,235 | $1.41 |
| May 22, 2026 | Rebecca Byam | Buy | 14,235 | $1.41 |
| May 22, 2026 | Rebecca Byam | Buy | 14,235 | $1.41 |
HCWB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-7.96M | -10.63 | $-13.39M |
| Dec 31, 2024 | — | $-30.02M | -30.96 | $-14.23M |
| Dec 31, 2023 | — | $-24.99M | -0.70 | $-22.51M |
| Dec 31, 2022 | — | $-14.90M | -0.42 | $-10.39M |
| Dec 31, 2021 | — | $-12.86M | -0.69 | $-10.98M |
Latest balance sheet: total assets $26.77M, total liabilities $19.34M, cash $741.32K (as of Jun 30, 2026).
HCWB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $2.68 |
| May 14, 2026 | 8-K Item 2.02 (results) | $2.02 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $2.16 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $18.00 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $26.04 |
| May 15, 2025 | 8-K Item 2.02 (results) | $49.20 |
| Mar 28, 2025 | 8-K Item 2.02 (results) | $72.00 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $74.16 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HCWB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.